New Paradigms Concerning the Production of Antibiotics: Between Ecological Responsibility and Revalorization of Narrow Spectrums

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "The Global Need for Effective Antibiotics".

Deadline for manuscript submissions: 10 February 2025 | Viewed by 7513

Special Issue Editor


E-Mail Website
Guest Editor
Infectious Diseases Department, Université Côte d’Azur, Centre Hospitalier Universitaire de Nice, 06000 Nice, France
Interests: infectious disease; pathogens; bacteriology

Special Issue Information

Dear Colleagues,

Despite clear warnings of increasing bacterial resistance and antimicrobial treatment failures due to inappropriate and excessive antibiotic use, there has been little progress in antibiotic stewardship over the past few decades. In this Special Issue, we share our views on the possible courses of action that could mitigate and even hopefully reverse the current situation, based on multifaceted approaches, which rely on a strong commitment on the part of governments, manufacturers, prescribers, and consumers. Although the detrimental role of antibiotics as growth factors in the food industry has been known for many years, few countries have taken the necessary steps, and only in Europe has this practice been discontinued. Recent studies have shown that it accounts for 20% of bacterial resistance in humans. Lately, awareness has been raised of the major role in the emergence and spread of antimicrobial resistance resulting from the production of antimicrobials in developing economies.

Stricter government control of antimicrobial manufacturing practices and of antimicrobial use in livestock should reduce the spread of antibacterial agents in the environment. This should be a mandatory requirement prior to granting a marketing license in any country. The addition of growth-promoting antibiotics in livestock should be banned. Physicians who have lost their clinical skills, due to the ease with which a broad-spectrum agent can cover a wide array of bacteria, need to acquire a keener knowledge of pathogen-specific clinical presentations. This would ensure targeted prescriptions with narrow-spectrum antimicrobial agents, thus limiting their impact on the gut flora and the emergence of resistance, while preserving more potent (?), broad-spectrum agents for severe conditions. Lastly, many patients remain unaware of the potential dangers of resistant bacteria and should be taught to refrain from consuming antimicrobials for conditions which are most often benign and/or of viral origin. Promotion of alternative approaches in such situations should be encouraged.

We would like this Special Issue to focus on a One Health perspective encompassing antimicrobial production, animal and human use, and related environmental concerns and give several practical proposals in order to initiate a reflection on change.

Dr. Véronique Mondain
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • one health
  • environmental pollution
  • human health
  • antimicrobial production
  • livestock
  • antimicrobial resistance
  • antimicrobial stewardship

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

11 pages, 562 KiB  
Article
Towards a Better Use of Antimicrobials on Farms: Insights from a Participatory Approach in the French Pig and Poultry Sectors
by Christian Ducrot, Marie-Jeanne Guénin, Anne Hemonic, Nathalie Rousset, Yannick Carre, Charles Facon, Philippe Le Coz, Jocelyn Marguerie, Jean-Marc Petiot, Maxime Jarnoux, Mily Leblanc-Maridor, Mathilde Paul, Sophie Molia and Catherine Belloc
Antibiotics 2022, 11(10), 1370; https://doi.org/10.3390/antibiotics11101370 - 7 Oct 2022
Cited by 2 | Viewed by 1945
Abstract
Despite the strong decrease in antimicrobial use in the French poultry and pig sectors over the last decade, room for improvement remains. A participatory approach was set up in France, involving representatives of veterinarians, the pig and poultry industries, technical institutes, the French [...] Read more.
Despite the strong decrease in antimicrobial use in the French poultry and pig sectors over the last decade, room for improvement remains. A participatory approach was set up in France, involving representatives of veterinarians, the pig and poultry industries, technical institutes, the French Ministry of Agriculture, and researchers, to further improve how antimicrobials are used on farms. By successively defining a shared, long-term vision of future antimicrobial use on farms, identifying lock-in mechanisms impeding this future vision from being realized, and articulating practical questions on how to move in the desired direction, the group rapidly reached a consensus. The results highlight the need for consensual standardized monitoring tools that would allow farmers and veterinarians to jointly monitor the health, welfare, antimicrobial resistance, and antimicrobial use on farms. Other results relate to better communication and training for citizens regarding animal health, animal welfare, and proper antimicrobial use; some benefits but also counterproductive effects of antibiotic-free labels that imperil animal health and welfare; the economic competitiveness of farms on international markets; and the economic sustainability of farm animal veterinary practices. These results call for a concerted way to produce tools for farmers and veterinarians and the broader involvement of other food sector actors. Full article
Show Figures

Figure 1

Other

Jump to: Research

8 pages, 2424 KiB  
Viewpoint
Advocacy for Responsible Antibiotic Production and Use
by Véronique Mondain, Nicolas Retur, Benjamin Bertrand, Florence Lieutier-Colas, Philippe Carenco and Sylvain Diamantis
Antibiotics 2022, 11(7), 980; https://doi.org/10.3390/antibiotics11070980 - 20 Jul 2022
Viewed by 2237
Abstract
Antibiotic-resistant bacteria have become one of humankind’s major challenges, as testified by the UN’s Call to Action on Antimicrobial Resistance in 2021. Our knowledge of the underlying processes of antibiotic resistance is steadily improving. Beyond the inappropriate use of antimicrobials in human medicine, [...] Read more.
Antibiotic-resistant bacteria have become one of humankind’s major challenges, as testified by the UN’s Call to Action on Antimicrobial Resistance in 2021. Our knowledge of the underlying processes of antibiotic resistance is steadily improving. Beyond the inappropriate use of antimicrobials in human medicine, other causes have been identified, raising ethical issues and requiring an approach to the problem from a “One Health” perspective. Indeed, it is now clear that the two main issues regarding the subject of antibiotics are their misuse in the global food industry and their method of production, both leading to the emergence and spread of bacterial resistance. Full article
Show Figures

Figure 1

8 pages, 268 KiB  
Perspective
The Production of Antibiotics Must Be Reoriented: Repositioning Old Narrow-Spectrum Antibiotics, Developing New Microbiome-Sparing Antibiotics
by Sylvain Diamantis, Nicolas Retur, Benjamin Bertrand, Florence Lieutier-Colas, Philippe Carenco, Véronique Mondain and on behalf of PROMISE Professional Community Network on Antimicrobial Resistance
Antibiotics 2022, 11(7), 924; https://doi.org/10.3390/antibiotics11070924 - 8 Jul 2022
Cited by 11 | Viewed by 2857
Abstract
The development of broad-spectrum antibiotics to control multidrug-resistant bacteria is an outdated business model. This strategy has led to the introduction of highly effective antibiotics, but their widespread use has contributed to the emergence of even broader antibiotic resistance. In a strategy to [...] Read more.
The development of broad-spectrum antibiotics to control multidrug-resistant bacteria is an outdated business model. This strategy has led to the introduction of highly effective antibiotics, but their widespread use has contributed to the emergence of even broader antibiotic resistance. In a strategy to combat antimicrobial resistance, we believe that the use of narrow-spectrum antibiotics should be promoted. This should involve both the repositioning of old antibiotics and the reorientation of research and development towards new narrow-spectrum antibiotics with a low ecological impact. These antibiotics could be prescribed for common conditions such as sore throats and cystitis, which account for the bulk of antibiotic use in humans. Narrow-spectrum, targeted, microbiome-sparing antibiotics could help control antibiotic resistance while being economically sustainable. Their development and production should be supported by governments, which would ultimately benefit from reduced health care costs. Full article
Back to TopTop